A review of efficacy and safety data regarding the use of liraglutide, a once-daily human glucagon-like peptide 1 analogue, in the treatment of type 2 diabetes mellitus-Reference-Cited by-同舟云学术

A review of efficacy and safety data regarding the use of liraglutide, a once-daily human glucagon-like peptide 1 analogue, in the treatment of type 2 diabetes mellitus

Published:2009-11 Issue:11 Volume:31 Page:2472-2488
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Montanya Eduard,Sesti Giorgio

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference81 articles.

1. Medical management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustments of therapy: A consensus statement of the American Diabetes Association and the European Association for Study of Diabetes;Nathan;Diabetes Care,2009

2. β-Cell failure in diabetes and preservation by clinical treatment;Wajchenberg;Endocr Rev,2007

3. UK prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: A progressive disease [published correction appears in Diabetes. 1996;45:1655];Diabetes,1995

4. Reduced insulin secretion/insulin resistance (disposition) index is the primary determinant of glucose intolerance in the prediabetic state: Results from ACT NOW;DeFronzo;Diabetes Care,2008

5. Improved beta-cell function after intensive insulin treatment in severe non-insulin-dependent diabetes;Glaser;Acta Endocrinol (Copenh),1988

Cited by 97 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Delayed Type Hypersensitivity Reaction Induced By Liraglutide With Tolerance to Semaglutide;JCEM Case Reports;2024-05-24

2. Usage of Glucagon-Like Peptide-1 for Obesity in Children; Updated Review of Clinicaltrials.gov;Journal of Multidisciplinary Healthcare;2023-07

3. Tirzepatide: A New Generation Therapeutic for Diabetes Type 2;Endocrine, Metabolic & Immune Disorders - Drug Targets;2023-07

4. Bolus Injection of Liraglutide Raises Plasma Glucose in Normal Rats by Activating Glucagon-like Peptide 1 Receptor in the Brain;Pharmaceuticals;2022-07-21

5. Contemporary Classification of Glucagon-Like Peptide 1 Receptor Agonists (GLP1RAs);Diabetes Therapy;2021-07-15